Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal

Por Minder, Elisabeth I, Schneider-Yin, Xiaoye, Minder, Christoph E
Publicado em 2010

Effects of different centrifugation conditions on clinical chemistry and Immunology test results

Por Minder, Elisabeth I, Schibli, Adrian, Mahrer, Dagmar, Nesic, Predrag, Plüer, Kathrin
Publicado em 2011

Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts

Por Bishop, David F., Schneider-Yin, Xiaoye, Clavero, Sonia, Yoo, Han-Wook, Minder, Elisabeth I., Desnick, Robert J.
Publicado em 2010

Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria

Por Frei, Pascal, Minder, Elisabeth I., Corti, Natascia, Muellhaupt, Beat, Geier, Andreas, Adams, Heiner, Dutertre, Jean-Paul, Rudiger, Alain, Dutkowski, Philipp, Maggiorini, Marco, Ganter, Christoph C.
Publicado em 2012

Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice

Por Barman-Aksözen, Jasmin, C´wiek, Paulina, Bansode, Vijay B., Koentgen, Frank, Trüb, Judith, Pelczar, Pawel, Cinelli, Paolo, Schneider-Yin, Xiaoye, Schümperli, Daniel, Minder, Elisabeth I.
Publicado no Dis Model Mech (2017)